To reduce selection bias , eligible subjects were randomized to 10-day , 12-day , or 14-day hybrid therapy consisting of esomeprazole 40 mg and amoxicillin 1 gm twice daily for 10 , 12 , or 14 days plus clarithromycin 500 mg , and metronidazole 500 mg twice daily for the final 7 days .